Literature DB >> 26155851

Prognostic Significance of Neuroadrenergic Dysfunction for Cardiovascular Events in Patients With Acute Myocardial Infarction.

Masatoshi Minamisawa1, Atsushi Izawa, Hirohiko Motoki, Yuichiro Kashima, Hirofumi Hioki, Naoyuki Abe, Takashi Miura, Soichiro Ebisawa, Yusuke Miyashita, Jun Koyama, Uichi Ikeda.   

Abstract

BACKGROUND: The dysregulation of systemic blood pressure (BP) variation or cardiac neuroadrenergic dysfunction is associated with adverse cardiovascular events. We aimed to clarify the prognostic significance of neuroadrenergic dysfunction for cardiovascular events in patients with acute myocardial infarction (AMI). METHODS AND 
RESULTS: We enrolled 63 AMI patients (mean age, 67±12 years) underwent ambulatory BP monitoring (ABPM) and cardiac iodine-(123)metaiodobenzylguanidine (MIBG) imaging within 4 weeks after AMI onset. We analyzed the circadian BP pattern and heart-to-mediastinum (H/M) MIBG uptake ratio. All the patients were followed for 2 years. The study endpoint was a composite of major adverse cardiovascular events, including all-cause death, MI, coronary revascularization except for the MI culprit lesion, and stroke. Patients with a non-dipper pattern (n=29) or an H/M ratio <1.96 (n=28) had a worse prognosis than those with either a dipper pattern (n=34) or an H/M ratio ≥1.96 (n=35; log-rank, P=0.013 and 0.010, respectively). Patients with both a non-dipper pattern and an H/M ratio <1.96 (n=12) had a significantly worse prognosis than did the other patients (P=0.0020).
CONCLUSIONS: Dysregulation of BP variation and cardiac MIBG uptake were associated with cardiovascular events following AMI. Examining ABPM with MIBG imaging may potentially improve risk stratification in these patients.

Entities:  

Mesh:

Year:  2015        PMID: 26155851     DOI: 10.1253/circj.CJ-15-0265

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  3 in total

Review 1.  The Sacubitril/Valsartan, a First-in-Class, Angiotensin Receptor Neprilysin Inhibitor (ARNI): Potential Uses in Hypertension, Heart Failure, and Beyond.

Authors:  Kazuomi Kario
Journal:  Curr Cardiol Rep       Date:  2018-01-27       Impact factor: 2.931

Review 2.  Circadian clock and the onset of cardiovascular events.

Authors:  Norihiko Takeda; Koji Maemura
Journal:  Hypertens Res       Date:  2016-02-18       Impact factor: 3.872

3.  Circadian Pattern of Acute Myocardial Infarction and Atrial Fibrillation in a Mediterranean Country: A study in Diabetic Patients.

Authors:  Stylianos Daios; Christos Savopoulos; Ilias Kanellos; Christos Argyrios Goudis; Ifigeneia Nakou; Stergiani Petalloti; Nicolas Hadjidimitriou; Dimitrios Pilalas; Antonios Ziakas; Georgia Kaiafa
Journal:  Medicina (Kaunas)       Date:  2021-01-06       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.